FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. - Wikidata - wikimedia - TriplyDB

FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.

FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.

http://www.wikidata.org/entity/Q34118590

about

Groundwater pesticide levels and the association with Parkinson disease Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson's Disease ALS Patient Stem Cells for Unveiling Disease Signatures of Motoneuron Susceptibility: Perspectives on the Deadly Mitochondria, ER Stress and Calcium Triad Molecular motor proteins and amyotrophic lateral sclerosis Trophic factors as modulators of motor neuron physiology and survival: implications for ALS therapy Therapeutic neuroprotective agents for amyotrophic lateral sclerosis Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1.Functional contribution of the transcription factor ATF4 to the pathogenesis of amyotrophic lateral sclerosis FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration Environmental Exposures and Parkinson's Disease Systems biology of neurodegenerative diseases Frontotemporal dementia: a bridge between dementia and neuromuscular disease Emerging mechanisms of molecular pathology in ALS Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis Nucleic acid-binding specificity of human FUS protein.Reduced expression of BTBD10, an Akt activator, leads to motor neuron death.Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion.Recruitment into stress granules prevents irreversible aggregation of FUS protein mislocalized to the cytoplasm Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions Accumulation of wildtype and ALS-linked mutated VAPB impairs activity of the proteasome.Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology.Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions.An evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALS Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS.Nuclear export of misfolded SOD1 mediated by a normally buried NES-like sequence reduces proteotoxicity in the nucleus.Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS A yeast model of FUS/TLS-dependent cytotoxicity.Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons.Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration Genetic biomarkers for ALS disease in transgenic SOD1(G93A) mice Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.Characterization of FUS mutations in amyotrophic lateral sclerosis using RNA-Seq.mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma.

P2860

Q23915922-1AC4494E-1ADE-4E6E-93E0-9991098D46A8 Q24600027-F7BAC0DE-9661-48FC-AFB8-C3016285B505 Q24634807-E0BF38FB-2B5D-4313-BA37-6242456B52A5 Q26768278-C0525687-6102-4F75-B247-1CCD8CBD3B25 Q26774824-A3B64CA1-48AB-46FA-A188-48001DAB6BFD Q26820831-9A241E91-02A1-42F4-8D8E-670EB431FB27 Q26999881-E9732728-6421-411F-A178-9BDF4DCA8615 Q27015029-3B2F944E-D318-4693-A0D7-F96C354DB4A2 Q27301265-484A3C64-FDC9-4583-854E-7686807ABABA Q27313877-E0002496-2324-43C6-ABF8-D0423CC6994E Q27339258-1F70203F-416D-469B-AF85-39832C9ACBA0 Q27342067-FED04A4B-5054-44AE-852A-C9B6BE61FCC4 Q28074723-57EBF1A7-9397-4181-86EC-B6BB889BF15A Q28080741-6D1FE8F2-552B-4FB1-B381-004777B0CB1D Q28081198-C6B0A923-F237-4523-9E82-C69393ADC03C Q28081239-DDC60629-4BC5-4FA1-AA35-0250B52EDC0C Q28084373-30E24AA5-D26E-49B8-8168-54F3A8A41B10 Q28383058-164114E5-6854-4C45-AC10-338F31FEFADB Q28728672-7AFC3B82-F939-427A-A30B-DA7D5C2CEE16 Q30459673-98E606B3-E054-4317-A501-38075AF71136 Q30519553-EA42E1D1-CCF0-44A4-B9E5-650BFB6F718A Q30532680-CD43BCDD-F079-4F70-BFBA-FC2F684A7D8A Q30559680-38D1166C-83D0-4A71-B5E8-51A6AFC61357 Q30661910-CE061E94-4437-474B-8CB1-13AA869D4708 Q31038125-5C266924-175B-451F-A764-C19D43D768C3 Q31058247-2929EA92-5EFD-406A-8D04-707024D93F68 Q31104690-5A1DC01D-5EE0-4681-B1C9-624D0BC0DED4 Q31153726-C132FCC2-89C8-4FD9-B992-2A034048EC22 Q33361835-14CF3E41-EE5C-4A8A-B20B-D9D3C6B7DFFC Q33687447-0156D338-C8E9-445A-B267-DB1A6C194574 Q33719399-6097B43D-3798-45FD-BD6D-D11EC9FF0726 Q33740006-24C6B4E9-6D3F-482C-B739-672BF6DFF220 Q33889532-64A6750D-48F5-4856-A8A3-38D13C380DCF Q33889537-C16EB98B-DF72-487F-B56E-8B6AB5C4A010 Q33987984-62917820-29C2-42B3-8573-208B0F9B1D4B Q34038343-447AD0DD-E162-4D2A-A524-73F77EFAA502 Q34193281-F6B11AA8-FC64-4C83-92C2-CCC115CD0F2D Q34222849-BFD5EB35-95ED-4F03-9C44-8270B18649C1 Q34663964-8F68B653-FF88-4FE2-AB2C-713C5462A6C8 Q34667328-5BCD9D51-482D-4916-A850-CEED89DFBA93

P2860

FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.

http://www.wikidata.org/entity/Q34118590

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

FUS-immunoreactive inclusions ...... amyotrophic lateral sclerosis.

@ast

FUS-immunoreactive inclusions ...... amyotrophic lateral sclerosis.

@en

FUS-immunoreactive inclusions ...... amyotrophic lateral sclerosis.

@nl

type

label

FUS-immunoreactive inclusions ...... amyotrophic lateral sclerosis.

@ast

FUS-immunoreactive inclusions ...... amyotrophic lateral sclerosis.

@en

FUS-immunoreactive inclusions ...... amyotrophic lateral sclerosis.

@nl

prefLabel

FUS-immunoreactive inclusions ...... amyotrophic lateral sclerosis.

@ast

FUS-immunoreactive inclusions ...... amyotrophic lateral sclerosis.

@en

FUS-immunoreactive inclusions ...... amyotrophic lateral sclerosis.

@nl

P1433

Q34118590-ECAB029E-D078-44F8-AFB7-549E8ADAC3CD

P1476

Q34118590-925A1A98-D5A9-43B1-A250-4766998EFD38

P2093

Q34118590-2851932B-57E3-4375-A155-3EB45BB53303

Q34118590-2D28322C-DEC5-417B-80F1-092678038268

Q34118590-386019C3-5C07-49C3-BBD8-F669BCD5C42C

Q34118590-4EAE15F5-0B98-4003-BAFD-742882BB75DD

Q34118590-60716989-43D6-4E63-B53A-664C03813F5D

Q34118590-678E65F4-454F-4EF9-8DE5-07EF11CDAAEB

Q34118590-697AD8C5-26A1-425F-9E55-66CA39805A54

Q34118590-7A875680-D854-481B-9085-B0697F488C0D

Q34118590-943AA416-B7A6-4BB6-AF06-4F3CA0F49D3D

Q34118590-D7A6A722-A723-4134-9031-E70897A4F7FE

P2860

Q34118590-021BFA10-9235-431C-BC76-DAD2CDE5A676

Q34118590-08E712DB-0FBF-460F-8B32-29FF2FEF87C6

Q34118590-0ED2268C-3277-4AB7-9317-CF85F6C0A51A

Q34118590-11EF9DD3-D3C4-4B02-8849-AD32949099C0

Q34118590-149F72B9-2A76-46BD-8E6F-D172F4F95CE1

Q34118590-248E4463-749C-4F68-9D75-C81488E84510

Q34118590-2C35514E-0473-4C59-91FA-32FBB89A1F96

Q34118590-327A99F0-C201-498D-A218-B5B73C01379E

Q34118590-32AD15DB-7EE0-4371-A9AF-A73EC2F66E0A

Q34118590-49D6883F-6F18-40CB-A806-1B26657A77EC

P304

Q34118590-893C93A2-3CFA-4C7F-AB04-CD155FA3282E

P31

Q34118590-E788A35C-30D3-472F-86F7-6B5E187F6B19

P356

Q34118590-DB41FC5C-3647-44BA-9EAC-0FEF5D28BDD7

P433

Q34118590-05184A83-8A31-4981-AC7A-E854C4FF0285

P478

Q34118590-755FA280-DCFF-4379-B41A-40846D100EF1

P577

Q34118590-E560038A-60A9-4E1A-8328-B253197ABEA1

P698

Q34118590-3C6158A2-22C6-4D9A-8CA4-D8CA7F192607

Q34118590-e20ec751-c73b-401b-9e22-00a30734d2b0

P921

Q34118590-3A1F9C13-9DAF-4322-A559-EF0582AE1130

P932

Q34118590-4B1F4ED8-815D-447C-AE3B-6F77882C58A2

P356

ARCHNEUROL.2010.101

P1433

Annals of Neurology

P1476

FUS-immunoreactive inclusions ...... amyotrophic lateral sclerosis.

@en

P2093

Eileen H Bigio

http://www.w3.org/2001/XMLSchema#string

Enrico Mugnaini

http://www.w3.org/2001/XMLSchema#string

Faisal Fecto

http://www.w3.org/2001/XMLSchema#string

Han-Xiang Deng

http://www.w3.org/2001/XMLSchema#string

Hong Zhai

http://www.w3.org/2001/XMLSchema#string

Jianhua Yan

http://www.w3.org/2001/XMLSchema#string

Kaouther Ajroud

http://www.w3.org/2001/XMLSchema#string

Manjari Mishra

http://www.w3.org/2001/XMLSchema#string

Nailah Siddique

http://www.w3.org/2001/XMLSchema#string

Robert Sufit

http://www.w3.org/2001/XMLSchema#string

P2860

Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease

A new subtype of frontotemporal lobar degeneration with FUS pathology

Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis

Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6

FUS pathology in basophilic inclusion body disease

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

P304

739-748

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUROL.2010.101

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20517935

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

4376270

http://www.w3.org/2001/XMLSchema#string